Affiliation:
1. Department of Sport and Management, IST University of Applied Sciences, Duesseldorf, Germany;
2. Department of Intervention Research in Exercise Training, German Sport University Cologne, Cologne, Germany;
3. Department of Movement and Training Science, University of Wuppertal, Wuppertal, Germany; and
4. Department of Exercise Training and Sports Informatics, German Sport University Cologne, Cologne, Germany
Abstract
Abstract
Held, S, Rappelt, L, Rein, R, Deutsch, J-P, Wiedenmann, T, and Donath, L. Five-week, low-intensity, blood flow restriction rowing improves V̇o
2max in elite rowers. J Strength Cond Res 38(6): e299–e303, 2024—This controlled intervention study examined the effects of low-intensity rowing with blood flow restriction (BFR) on maximal oxygen uptake (V̇o
2max), peak power output during ramp testing (PPO), and 2000-m time trial performance (P2k). Eleven, highly elite, male rowers (22.1 ± 1.6 years; 92.6 ± 3.8 kg; 1.93 ± 0.04 m; 7.9. ± 2.2 years rowing experience; 20.4 ± 2.0 h·w−1 training volume; 11.9 ± 1.1 session per week) trained 5 weeks without BFR (Base) followed by a 5-week BFR intervention period. BFR of the lower limb was applied through customized elastic wraps. BFR took place 3 times a week (accumulated net pBFR: 60 min·wk−1; occlusion per session: 2 times 10 min·session−1) and was used exclusively at low intensities (<2 mmol·L−1). V̇o
2max, PPO, and P2k were examined before, between, and after both intervention periods. Bayesian’s credible intervals revealed relevantly increased V̇o
2max +0.30 L·min−1 (95% credible interval: +0.00 to +0.61 L·min−1) adaptations through BFR. By contrast, PPO +14 W (−6 to +34 W) and P2k −5 W (−14 to +3 W) were not noticeably affected by the BFR intervention. This study revealed that 15 sessions of BFR application with a cumulative total BFR load of 5 h over a 5-week macrocycle increased V̇o
2max remarkably. Thus, pBFR might serve as a promising tool to improve aerobic capacity in highly trained elite rowers.
Funder
Bundesinstitut für Sportwissenschaft
Publisher
Ovid Technologies (Wolters Kluwer Health)